On the 1st of October, the newest NOME companies presented at the latest mentor matchmaking event, and now the mentor teams are created. For the next two years, the following companies will work with their new mentors to propel them even further than they have already come:
Sortina Pharma develops small-molecule therapies that target sortilin, a key protein involved in cancer and neurodegenerative diseases. By modulating this pathway, they aim to create novel, precise treatments to slow disease progression and improve patient quality of life, advancing innovation in life sciences and precision medicine.
Connected Consumables develops medical connectors that integrate fluid delivery with data communication and inductive power. By enhancing standard Luer connectors, their technology supports safer, automated infusion therapy, reduces human error, and provides actionable clinical information, helping hospitals and healthcare providers deliver better patient care.
Akasi Pharma is focused on non-opioid therapeutics for diabetic peripheral neuropathic pain. Their drugs target somatostatin receptor 4, aiming to reduce nerve pain safely and effectively, offering an innovative alternative to conventional treatments and improving quality of life for patients with chronic neuropathic conditions.
ToxoTech develops advanced botulinum toxin therapies targeting neuromuscular and neurological disorders. Their innovative approach aims to improve efficacy, safety, and precision, offering enhanced therapeutic options for patients and healthcare providers, and driving new possibilities in clinical treatment of muscle-related and neurological conditions.
Loma Therapeutics focuses on immunotherapies designed to treat and prevent HPV-related cancers. By selectively activating T-cells, their therapies aim to boost the body’s immune response against cancerous cells, offering new hope for patients and advancing the field of targeted oncology immunotherapy.